Koyfin Home > Directory > Health Care > Alder Biopharma > EV / EBITDA (ltm)

Alder Biopharma EV / EBITDA (ltm) Chart (ALDR)

Alder Biopharma annual/quarterly EV / EBITDA (ltm) from 2014 to 2015. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Alder Biopharma EV / EBITDA (ltm) for the quarter ending May 05, 2015 was 106.24 a 5.33% increase of 5.66 year over year
  • Alder Biopharma EV / EBITDA (ltm) for the last 12 months ending May 05, 2015 was 106.24 a 5.33% increase of 5.66 year over year
  • Alder Biopharma Annual EV / EBITDA (ltm) for 2015 was 106.24 a 3.60% increase of 3.83 from 2014
  • Alder Biopharma Annual EV / EBITDA (ltm) for 2015 was 102.41 a -2.57% decrease of -2.63 from 2014
  • Alder Biopharma Annual EV / EBITDA (ltm) for 2015 was 105.04 a 4.25% increase of 4.47 from 2014
Other Valuation Metrics:
  • Alder Biopharma Market Cap for the quarter ending March 03, 2018 was $862m a 33.01% increase of 284m year over year
  • Alder Biopharma Price / Book for the quarter ending March 03, 2018 was 3.09 a 34.98% increase of 1.08 year over year
  • Alder Biopharma Enterprise Value for the quarter ending March 03, 2018 was $585m a 50.86% increase of 298m year over year
View Chart On Koyfin

Quarterly ALDR EV / EBITDA (ltm) Data

05/2015106.24
05/2015102.41
05/2015105.04
05/2015100.58
04/201595.79
04/201588.54
04/201583.99
04/201588.62
04/201594.20
04/201595.19

Annual ALDR EV / EBITDA (ltm) Data

2015106.24
2015102.41
2015105.04
2015100.58
201595.79
201588.54
201583.99
201588.62
201594.20
201595.19